Proto-oncogenes like c-myc are thought to control exit from the cell cycle rather than progression through the cell cycle itself. We now present a dierent view of Myc function. Exponentially growing Rat1-MycER TM ®bro-blasts were size-fractionated by centrifugal elutriation. In these cells, activation of cyclin E-and cyclin Adependent kinases, degradation of p27, hyperphosphorylation of retinoblastoma protein and activation of E2F occur sequentially at speci®c cell sizes. Upon activation of Myc, however, these transitions all occur simultaneously in small cells immediately after exit from mitosis. In contrast, Myc has no discernible eect on the cell size at which DNA replication is initiated. These data show ®rst that Myc controls the activity of G1 cyclin-dependent kinases independently from the transition between quiescence and proliferation and from any eect on cell growth in size. These data also provide evidence of at least one dominant mechanism besides activation of E2F and of cyclin E/cdk2 kinase, which prevents DNA replication unless a critical cell size has been reached.
Introduction
Passage through the cell cycle depends on an increase in cell size. In eukaryotic cells, initiation of DNA replication does not occur until cells reach a minimum size (Killander and Zetterberg, 1965) . In yeast, this control acts at a point in G1 which is called START (Nurse and Bisset, 1981) . Similarly, in mammalian cells commitment to DNA replication is thought to occur at a speci®c point, termed restriction point, in mid G1 phase (Rossow et al., 1979) . Whether, the size control of mammalian cells also acts at the restriction point is not known; however, many events used to de®ne passage through the restriction point are size-dependent in exponentially growing mammalian cells (Zetterberg et al., 1995) .
Many genes that control mammalian cell proliferation are proto-oncogenes, cellular homologues of the transduced oncogenes of retroviruses. Induction of oncogene activity is often strongly mitogenic and can be sucient to induce proliferation in resting cells. For example, induced expression of transforming alleles of ras (Winston et al., 1996) or activation of temperaturesensitive alleles of v-src stimulates cell cycle entry in resting cells (Welham et al., 1990) . One striking example for this is provided by the c-myc gene. c-myc encodes a transcription factor (Myc) of the helix ± loop ± helix/leucine zipper class of proteins (for review, see Amati and Land, 1994; Bernards, 1995) . Myc protein binds to speci®c DNA sequences (termed Eboxes) as part of a heterodimeric complex with a partner protein called Max (Blackwell et al., 1990; Blackwood and Eisenman, 1991; Kerkho et al., 1991; . The complex is a potent activator of transcription (Amati et al., 1992; Kretzner et al., 1992; Amin et al., 1993) . Induction of conditional alleles of c-myc is sucient to stimulate cell cycle re-entry and proliferation in resting cells (Eilers et al., 1991) . Both the ability to bind to DNA and to interact with Max are necessary for the mitogenic properties of Myc, strongly suggesting that Myc acts by transcriptionally activating a critical set of target genes (Stone et al., 1987; Amati et al., 1993a; Amati et al., 1993b) .
Several models are conceivable to explain how Myc might stimulate proliferation. First, Myc might stimulate growth in cell size by activating transcription of genes which encode rate-limiting metabolic enzymes. Potential examples for such target genes encode CAD (Carbamoyl-phosphate synthase/aspartate carbamoyltransferase/dihydroorotase), a rate limiting enzyme in pyrimidine biosynthesis (Miltenberger et al., 1995) and ornithine decarboxylase, the rate limiting enzyme of polyamine biosynthesis (Bello-Fernandez et al., 1993) . Polyamines stimulate a wide variety of biological processes (Tabor and Tabor, 1984) ; thus, induction of ornithine decarboxylase and CAD expression by Myc might contribute to cell growth and thus indirectly lead to cell proliferation. Alternatively, Myc might directly stimulate genes that encode components of the`cell cycle machinery' and thus stimulate proliferation directly rather than indirectly via a possible eect on cell growth. This latter model predicts that Myc should activate downstream targets in the cell cycle independent of cell size and overt eects on cellular proliferation.
Closely related is the question which molecular events are used by a cell to ascertain that a critical cell size for the initiation of DNA replication has been reached. In exponentially growing mammalian cells, E2F-dependent transcription, hyperphosphorylation of retinoblastoma protein (pRb) and transcription and activation of the cyclin E-and cyclin A-dependent kinases are periodic and are initiated before the onset of DNA replication. These events are required for entry of a cell into S-phase (reviewed in Nigg, 1995; Weinberg, 1995; Pines, 1995) ; activation of cyclindependent kinases (cdk) can be rate limiting for passage through G1 (Ohtsubo and Roberts, 1993; Resnitzky et al., 1994; Resnitzky and Reed, 1995) . But it is open whether these events are actually sucient to stimulate DNA synthesis or whether additional controls ascertain that S-phase is only initiated after cells have grown in size.
We have addressed both issues using Rat1 fibroblasts which carry a hormone-inducible allele of the cmyc proto-oncogene (MycER TM ; Eilers et al., 1989; Steiner et al., 1995) . Previous work has demonstrated that activation of Myc in resting cells leads to a rapid activation of cyclin E/cdk2 kinase (Steiner et al., 1995) ; cyclin E/cdk2 in turn transactivates the E2F transcription factor and expression of cyclin A (Rudolph et al., 1996) . We have now size-fractionated exponentially growing Rat1-MycER TM cells by centrifugal elutriation, either in the presence or absence of activated Myc. Under these conditions induction of Myc causes activation of cyclin D, cyclin E-and cyclin Adependent kinases, degradation of the cdk inhibitor p27, and E2F dependent transcription independent of cell size. These data show unequivocally that c-myc controls the activity of cyclin-dependent kinases independent from any eect on exit or entry into the cell cycle or from cell size. Second, we show that even in the presence of active cyclin D1, cyclin E-and cyclin A-dependent kinases and of active E2F, Rat1 cells grow to normal size before they initiate DNA replication and replication-dependent transcription of the histone H4 gene. Thus, at least one dominant mechanism must exist that monitors the size requirement of DNA replication.
Results
To explore potential eects of Myc on cell cycle progression in exponentially growing cells, Rat1-MycER TM cells were seeded at low density, either in the presence or absence of hydroxy-tamoxifen (4-OHT). Twenty-four hours later, the cell cycle distribution was determined cyto¯uorometrically. Under these conditions, Rat1-MycER TM cells showed a cell cycle distribution characteristic of growing cells both in the presence or absence of activated Myc (Figure 1a) . Quantitiation of multiple experiments showed that induction of Myc caused a marginal decrease in the number of G1 phase cells (from 53%+3 to 45%+2) with an concomitant increase in the number of S phase cells. Variation of the incubation times with 4-OHT between 20 and 40 h yielded no signi®cant dierences. 4-OHT had no eect on cell cycle distribution in Rat1 cells stably infected with the empty retroviral vector (Rat1-pBpuro) or in cells expressing a non-functional allele of Myc (Rat1-DelMycER) (Stone et al., 1987; Eilers et al., 1989) in which residues 106 ± 143 of Myc are deleted. In parallel, determination of the cell doubling time by cell counting showed a small reduction in the doubling time of induced versus non-induced cells (from 13 h to about 12.5 h, Figure 1b) . We concluded that Myc has little overt eect on cell cycle progression of exponentially growing Rat1-MycER TM cells and induced a maximally 8% decrease (corresponding to 30 min of a total length of 7.6 h) in the duration of G1 phase. Next, we asked whether Myc-induced cells initiate DNA replication at the same cell size as their noninduced counterparts. To address this question we separated cells according to cell size phases by centrifugal elutriation. The advantage of this synchronization procedure is that cells, which have never been forced to leave the cell cycle, are separated without the use of drugs. Isolated cells were arbitrarily assigned to seven narrow size classes and the DNA content of each class was determined by staining with propidium iodide. Alternatively, small G1 cells were isolated and replated in the presence of 10% FCS either with or without 4-OHT. These cells entered S phase with a degree of synchrony (about 60%), that is signi®cantly higher than that observed with other synchronization procedures (Steiner et al., 1995; HengstschlaÈ ger et al., 1994b; . Comparing Myc-induced and noninduced Rat1-MycER TM cells, we found in both types of experiment that the onset of DNA replication in Myc-overexpressing cells occurs at the same cell size as in normal cells (Figure 2 ).
Previously Myc has been shown to upregulate expression of cyclin A and, to a lesser extent, cyclin E , 1993) . We wondered whether Myc aected expression of cyclins A, E and D in exponentially dividing Rat1-MycER TM cells. Fractions obtained by centrifugal elutriation from induced or non-induced cells, respectively, were analysed for cyclin mRNA expression by Northern blotting. In untreated cells, cyclin E mRNA expression increased during G1 and decreased after S phase. Cyclin A mRNA expression was induced at the G1/S boundary and remained at a high level until the next G1 phase. In contrast, no signi®cant cell cycle¯uctuation of cyclin D1 and cyclin D3 mRNA expression was observed (Figure 3 ; expression of Cyclin D2 mRNA was not detectable in these cells). Similar observations were made in other cell lines (Motokura and Arnold, 1993) . Activation of wild-type Myc triggered strong upregulation of cyclin A and E mRNA expression in very early G1 cells, abrogating the cell cycle regulation of either mRNA. Cyclin D1 expression was slightly downregulated, whereas cyclin D3 expression was unaected by Myc (Figures 3 and 4a) . Western blot analyses showed that the Myc-dependent induction of cyclin mRNA in early G1 cells was paralleled by an induction of cyclin protein (Figure 4a) . Overexpression of the inactive (del 106 ± 143) MycER protein had no eect on the expression of these cyclins (not shown).
Cyclin A and cyclin E proteins are activating subunits of cdk2. Cyclin A-as well as cyclin Eassociated kinase activities are low in G1 and are induced at the G1/S boundary, at a point where cells have reached a critical size (Dulic et al., 1992; Pagano et al., 1992 Pagano et al., , 1993 Ko et al., 1992) . We determined cyclin E-and A-kinase activities and the amount of p27 and Cdc25A protein in parallel (Figure 4) . In control cells, we observed a strong regulation of both activities throughout the cell cycle: cyclin E-dependent kinase activity was activated in mid to late G1. Cyclin A-dependent kinase activity was activated at the G1/S boundary. In contrast, upon induction of Myc, both cyclin E-and cyclin A-dependent kinase activities remained high throughout the cell cycle; at maximum, a two-fold regulation in very early G1 could be observed. D1-type-cyclin-associated kinase activity was essentially independent of cell size in our assays; it was slightly activated by Myc at all cell cycle phases. Speci®city of the D1-kinase assays was ascertained by usage of an isotype-matched control antibody. Kinase signals using control antibodies were about 15-fold lower than the shown signals for uninduced Rat1-MycER TM cells (data not shown; compare Steiner et al., 1995) . Degradation of p27 was initiated in very early G1 immediately after exit from mitosis in Myctransformed cells; no p27 was detectable in mid G1 cells. In contrast, p27 is present into S-phase of control cells. We did not detect any eects of Myc on the expression levels of Cdc25A protein (Figure 4a) .
To address the biological consequences of these observations, we analysed potential downstream targets of cdk2, one of which is the retinoblastoma protein (Nigg, 1995; Weinberg, 1995; Pines, 1995) . Western blot analysis of the elutriated fractions of uninduced Rat1-MycER TM cells showed a transition from the hypophosphorylated to the hyperphosphorylated form of pRb in mid G1, as previously demonstrated in many cell lines (Figure 4; Nigg, 1995; Weinberg, 1995; Pines, 1995) . In contrast, induced Rat1-MycER TM cells exhibited hyperphosphorylated pRb throughout the whole cell cycle, even in the ®rst elutriated fraction containing early G1 cells (Figure 4) . These results Hyperphosphorylation of pRb during G1 prevents its interactions with E2F, thus liberating transcriptionally active`free' E2F (MuÈ ller, 1995) . We analysed complex formation on the E2F binding site of the adenovirus E2 promoter. The formation pattern of the dierent obtained complexes were identical to that described earlier (Figure 5a ; Pagano et al., 1992) . The upper bands represent transcriptionally inactive E2F complexes containing pocket proteins (Pagano et al., 1992) . We identi®ed`free' transcriptional active E2F by treatment with deoxycholate, which dissociates pocket-protein complexes of E2F (arrow in Figure 5a ; Bagchi et al., 1990) . We detected a signi®cant Mycinduced increase in the amount of`free' E2F in logarithmically growing and in early small G1 cells (Figure 5a and b) . There were no dierences in the formation of E2F complexes after treatment of the control cells Rat1-pBabepuro or Rat1-DelMycER with 4-OHT (data not shown). This experiment further revealed that the total level of E2F activity was increased upon activation of Myc (Figure 5a ).
To test whether the increase in free E2F was paralleled by an increase in E2F-dependent transcription, we decided to analyse the eects of c-Myc overexpression on cell cycle regulation of the E2F dependent transcription of the thymidine kinase (TK) and the dihydrofolate reductase (DHFR) gene. 1994b Dou et al., 1994) . Northern blot experiments of uninduced Rat1-MycER TM cells after centrifugal elutriation con®rmed this regulation ( Figure  5c and d) . Activation of Myc causes high levels of TK and DHFR mRNA already in early small G1 cells. In contrast, the cell cycle dependence of histone H4 transcription, which is not mediated by E2F, remained unaected by Myc activation (Figure 5c and d) .
Discussion
In this paper, we show that activation of Myc relieves the size requirement for a number of key transitions during the G1 phase of the mammalian cell cycle, thereby uncoupling these events from normal cell cycle progression. In addition, we show that, even in the presence of active E2F-dependent transcription and of active cyclin-dependent kinases cells delay initiation of DNA replication until they have reached a normal cell size.
Previous work had demonstrated that induction of Myc in resting cells triggers a rapid induction of cyclin E/cdk2 kinase activity (Steiner et al., 1995) . While these observations provided tools to understand the mitogenic function of Myc, one of the key questions remained unresolved: whether the observed eects are an indirect re¯ection of Myc's mitogenic properties or whether they indeed de®ne a genetic pathway in which Myc controls the activity of the cyclin E/cdk2 kinase independent of the status of the cell. The data presented here resolve the issue. Under the conditions of the experiments (i.e. in exponentially growing cells) Myc has no signi®cant eect on cell cycle progression, 98  96  91  81  14  14 15  98  96 92  84  12  15 19  1  3  6  16  74  22 11  1  2  6  14  76  28 10  1  1  3  3  12  64 74  1  2  2  2  12  57 cell growth and initiation of DNA replication. Nevertheless, activation of Myc almost completely abolishes the cell cycle regulation of the cyclin E-and cyclin Adependent kinases and results in cell cycle independent hyperphosphorylation of pRb and E2F-dependent transcription. Our data predict the existence of direct targets of Myc in the activation of the cyclin E/cdk2 kinase complex. In resting cells Myc-induced loss of p27 from cyclin E/cdk2 complexes is the rate limiting step for activation (Steiner et al., 1995) . The precise mechanism of this reaction and the putative targets are yet unknown and currently under investigation. Although it has recently been shown that Cdc25A is a direct target for activation by Myc (Galaktionov et al., 1996) , our data show that Myc-dependent induction of cyclin-dependent kinase activities in early G1 phase is not caused by increased levels of Cdc25A.
One of the hallmarks of Myc-transformed cells is their often complete insensitivity to growth factor deprivation for entry into S-phase (Eilers et al., 1991; Evan et al., 1992) . In contrast, non-transformed counterparts enter this state in mid G1. The transition from growth factor sensitivity to insensitivity has been termed restriction point and re¯ects the time when cells become committed to DNA replication (Rossow et al., 1979) . Passage through the restriction point correlates closely with the onset of cyclin E and cyclin A expression and with hyperphosphorylation of pRb (Dou et al., 1993) . Our data suggest that Myctransformed Rat1 cells are equivalent to post-commitment normal cells for the entire duration of their G1 phase and never enter the growth factor sensitive phase of the cell cycle of their non-transformed counterparts. Thus, the Myc-induced change in cell cycle progression reported here would be sucient to explain the resistance to growth factor deprivation that is observed in Myc-transformed cells.
Our ®ndings that Myc cells do not start replication although they already express E2F-dependent transcription are in apparent contrast with recent observations that ectopic expression of E2F alone is sucient to drive resting cells into S-phase (Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994; DeGregori et al., 1995; Kowalik et al., 1995) . However, the size at which these cells initiate DNA synthesis has not been determined and it is conceivable that arrested E2F-expressing cells actually grow signi®cantly before DNA synthesis. In support of this notion, we have recently analysed Rat1 cells expressing a conditionally inducible E2F gene and found that, upon induction, E2F-dependent transcription is active already in very small G1 cells, yet there is no discernible eect on the size at which replication is initiated (T Soucek, O Pusch and M HengstschlaÈ ger, in preparation). Further, our data suggest that the signi®cant reduction of cell size at entry into S-phase and length of G1 that is observed in cells overexpressing both cyclins D1 and E (Resnitzky et al., 1994; Resnitzky and Reed, 1995) may not simply be due to premature activation of cyclindependent kinases. If that were the case, we would expect to observe similar eects in Myc-transformed cells. Rather, it appears that the high levels of overexpression of both cyclins D1 and E in such cells at least in part override size control mechanisms that are still intact under physiological cyclin expression levels of Myc-transformed cells.
At present, there is no indication as to how this additional size control might act in mammalian cells. Assuming that this control is also exerted by kinases, potential candidates include cdk3. Although cdk3 has never been found in association with cyclins, because of high sequence identity with both cdc2 and cdk2 and the ability to complement cdc28 mutations in yeast, it was classi®ed as a cyclin-dependent kinase (Meyerson et al., 1992) . It has been demonstrated that cdk3 executes an essential function regulating S-phase entry, which is distinct from the functions of cdc2 and cdk2 (Van der Heuvel and Harlow, 1993; Hofmann and Livingston, 1996) . In yeast, another kinase, cdc7, and its activating subunit, dbf4, are required to initiate DNA replication and interact directly with replication origins (Dowell et al., 1994) . Mammalian homolouges of these latter genes have not been identi®ed. However, forms of control other than by cyclin/cdk complexes are easily conceivable and thus further work will be required to identify the responsible mechanisms.
Materials and methods
Cell culture, centrifugal elutriation and¯ow cytometry.
Establishment and cultivation of the Rat-1 cell lines used in this study have been described previously (Eilers et al., 1989; Littlewood et al., 1995) . Myc functions were activated with 100 nM 4-hydroxytamoxifen (4-OHT). Separation of logarithmically growing cells into distinct cell cycle phases was accomplished by centrifugal elutriation in a Beckman J2 ± 21 M centrifuge and a JE ± 6B rotor with a standard separation chamber (HengstschlaÈ ger et al., 1994a) . The rotor was kept at a speed of 2000 r.p.m., temperature was 208C, and medium¯ow was controlled with a Cole-Parmer Master¯ex pump. Consecutive fractions of 150 ± 300 ml were collected at increasing¯ow rates. Cyto¯uorometric analyses of cell cycle distributions were performed using a Becton-Dickinson FACScan. DNA was stained with propidium iodide (Giunta and Pucillo, 1995).
Cell size in femtoliter was determined with a Casy Cell Counter and Analyser (SchaÈ rfe System).
Western blot and Northern blot analyses
Protein extracts were prepared in buer containing 20 mM HEPES pH 7.9, 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ml benzamidinchloride, 0.1 mg/ml trypsin inhibitor and 0.5 mM DTT. After 20 min on ice, the extracts were centrifuged and supernatants were stored at 7708C. Western blot analyses were performed as described (Steiner et al., 1995) . The following antibodies were used: against cyclin E, M20 (sc-481, St. Cruz); cyclin A, H432 (sc-751, St. Cruz); cyclin D1 (DCS-6, Progen); p27, C19 (sc-528, St. Cruz); Cdc25A, 144 (sc-97, St. Cruz); pRb, 14001A (Pharmingen) (see also Steiner et al., 1995) .
The used protocol for RNA extraction and Northern blot analysis is described in HengstschlaÈ ger et al. (1996) . Hybridizations probes were full length human or mouse cyclin A, cyclin E, cyclin D1, cyclin D3, dihydrofolate reductase, thymidine kinase, histone H4 and a 1300 bp fragment of the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. 
Immunoprecipitations and immune complex kinase assays
Protein extracts were prepared as described above. Cyclin immunoprecipitations and analyses of cyclin-dependent kinases were performed according to Dulic et al. (1992) . The following antibodies were used: against cyclin E, M20 (sc-481, St. Cruz); cyclin A, H432 (sc-751, St. Cruz); cyclin D1 (DCS-11, NeoMarkers); substrate for cyclin A-and Eassociated kinase detection was histone H1, for cyclin D1-kinase GST-pRb (Steiner et al., 1995) .
Band shift analyses
Protein was extracted as described above. Gel mobility shift analyses were carried out with 5 ± 10 mg extract as described by Jansen-DuÈ rr (1995) . Synthetic oligonucleotides corresponding to both strands of the wildtype or mutant distal E2F binding site of the adenovirus E2 promoter were used (oligos are described in Pagano et al., 1992) . Deoxycholate treatment was performed as described (Bagchi et al., 1990) .
